SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+24.46%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$963M
AUM Growth
+$963M
(+11%)
Cap. Flow
-$20.1M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
42.67%
Holding
134
New
41
Increased
18
Reduced
32
Closed
26
Top Buys
| 1 |
Eli Lilly
LLY
|
$42.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
$38.8M |
| 3 |
ONCR
Oncorus, Inc.
ONCR
|
$28.4M |
| 4 |
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
|
$26.1M |
| 5 |
C4 Therapeutics
CCCC
|
$14.6M |
Top Sells
| 1 |
Sanofi
SNY
|
$56.2M |
| 2 |
AbbVie
ABBV
|
$48.2M |
| 3 |
Amgen
AMGN
|
$28M |
| 4 |
Amicus Therapeutics
FOLD
|
$22.6M |
| 5 |
Sarepta Therapeutics
SRPT
|
$16.5M |
Sector Composition
| 1 | Healthcare | 79.61% |
| 2 | Technology | 10.28% |
| 3 | Industrials | 3.68% |
| 4 | Consumer Discretionary | 2.21% |
| 5 | Communication Services | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Amicus Therapeutics
FOLD
$2.34B
| $6.14M | 0.54% | 265,753 -977,797 | -79% | -$22.6M |
|
52
Krystal Biotech
KRYS
$4.27B
| $6.06M | 0.54% | 101,044 -83,529 | -45% | -$5.01M |
|
|
DCPH
53
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $5.91M | 0.52% | 103,565 -240,400 | -70% | -$13.7M |
|
54
Iovance Biotherapeutics
IOVA
$807M
| $5.91M | 0.52% | 127,289 -125,711 | -50% | -$5.83M |
|
55
Allot
ALLT
$362M
| $5.61M | 0.5% | 533,192 -512,145 | -49% | -$5.39M |
|
56
Nova
NVMI
$7.74B
| $5.52M | 0.49% | +78,113 | New | +$5.52M |
|
57
Praxis Precision Medicines
PRAX
$958M
| $5.5M | 0.49% | +100,000 | New | +$5.5M |
|
58
ARKO Corp
ARKO
$564M
| $5.4M | 0.48% | +600,000 | New | +$5.4M |
|
59
VistaGen Therapeutics
VTGN
$102M
| $5.29M | 0.47% | +2,725,000 | New | +$5.29M |
|
60
Ionis Pharmaceuticals
IONS
$6.8B
| $5.19M | 0.46% | +91,800 | New | +$5.19M |
|
|
CNCE
61
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.85M | 0.43% | 384,039 +74,039 | +24% | +$936K |
|
|
GRTX
62
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $4.78M | 0.42% | 467,662 -1,583 | -0.3% | -$16.2K |
|
|
DRNA
63
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.78M | 0.42% | 216,980 +17,000 | +9% | +$375K |
|
64
Galecto
GLTO
$4.21M
| $4.67M | 0.41% | +391,787 | New | +$4.67M |
|
65
ESSA Pharma
EPIX
$11.4M
| $4.66M | 0.41% | 390,200 +140,200 | +56% | +$1.67M |
|
66
KalVista Pharmaceuticals
KALV
$678M
| $4.56M | 0.4% | 240,140 | – | – |
|
67
JFrog
FROG
$5.76B
| $4.55M | 0.4% | 72,377 -23,038 | -24% | -$1.45M |
|
68
Sutro Biopharma
STRO
$72.7M
| $4.38M | 0.39% | +201,600 | New | +$4.38M |
|
69
Nautilus Biotechnolgy
NAUT
$85.9M
| $4.34M | 0.39% | 400,000 | – | – |
|
70
Rocket Pharmaceuticals
RCKT
$354M
| $4.11M | 0.37% | 75,000 -153,016 | -67% | -$8.39M |
|
71
Ascendis Pharma
ASND
$11.8B
| $3.94M | 0.35% | 23,599 -9,000 | -28% | -$1.5M |
|
72
Wave Life Sciences
WVE
$1.53B
| $3.27M | 0.29% | 414,959 -516,241 | -55% | -$4.06M |
|
|
KDNY
73
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.2M | 0.28% | +201,666 | New | +$3.2M |
|
74
Shattuck Labs
STTK
$47M
| $2.9M | 0.26% | +55,300 | New | +$2.9M |
|
75
argenx
ARGX
$43.6B
| $2.72M | 0.24% | 9,249 -1,016 | -10% | -$299K |
|